Ataxia
3 drugs96 FAERS reportsMedDRA PT
GET
/api/v1/reaction/ataxiaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D001259
Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Drugs reporting Ataxia (3)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Thallium13.3%
- 2Ethosuximide793.2%
- 3Bromine163.0%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
Literature
Recent PubMed references pinned to Ataxia as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Aromatic-Turmerone Analogs Activate Chaperone-Mediated Autophagy and Ameliorate Dendritic Shrinkage in Purkinje Cell Models of Spinocerebellar Ataxia.Biological & pharmaceutical bulletin · 2026 · Motomura K, Ueda-Ishizaka E, Boateng A, et al.PMID 42203458DOI 10.1248/bpb.b26-00103
- Intermittent Theta-Burst Stimulation (iTBS) Improves Motor Coordination and Modulates Neuroinflammation and Autophagy in SCA3/MJD Mice.Cerebellum (London, England) · 2026 · Chen LW, Lian YH, Dong XL, et al.PMID 42183960DOI 10.1007/s12311-026-02027-w
- Establishment of spinocerebellar ataxia type 34 model mice accompanied by early glial activation and degeneration of cerebellar neurons.Journal of pharmacological sciences · 2026 · Morikawa-Yujiri Y, Motomura K, Konno A, et al.PMID 42173623DOI 10.1016/j.jphs.2026.04.004
- SCA27B in Brazil: frequency, phenotype and genotype-phenotype correlations.Journal of neurology · 2026 · de Jesus Araujo Dias A, Silveira C, Vinagre AM, et al.PMID 42168446DOI 10.1007/s00415-026-13880-4
- An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar Ataxia.PLoS genetics · 2026 · Brown BN, Dahlgren AR, Ghosh S, et al.PMID 42160398DOI 10.1371/journal.pgen.1012158
- A Case Report of Reversible Mitochondrial Bioenergetic Dysfunction in PBMCs in Anti-GAD65-Associated Cerebellar Ataxia.Cerebellum (London, England) · 2026 · Huňarová N, Verešpejová AI, Grófik M, et al.PMID 42156614DOI 10.1007/s12311-026-02025-y
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.